Urinary cathecholamines, serum neurone specific enolase, alpha-fetoprotein (AFP) and chorionic gonadotropin have a diagnostic role as tumour markers in children with malignancies. The new generation of tumour markers based on monoclonal antibodies has been extensively studied in adult patients but little is known about their occurence in children.
The CA 125 antigen is based on monoclonal antibodies originally raised against an ovarian serous cystadenocarcinoma cell line and it associates in serum with mucin fraction (Bast et al., 1983) . Serum CA 125 is elevated in about 80% of patients with ovarian cancer (Haglund, 1986) , but it may also be elevated in patients with other gynaecological or gastrointestinal malignancies, and during pregnancy (Halila et al., 1986) .
CA 19-9 is a tumour marker raised against a human colorectal cell line (Koprowski et al., 1979) . CA 19-9 is immunohistochemically detectable in specimens from different gastrointestinal cancers or from normal pancreas, stomach, liver and gallbladder (Atkinson et al., 1982; Haglund et al., 1986a) . The serum concentrations are elevated particularly in patients with pancreas cancer (Haglund et al., 1986b; Herlyn et al., 1982) , but also in patients with other gastrointestinal cancer or some benign gastrointestinal diseases .
Serum CA 19-9 and CA 125 measurements have not been shown to be of clinical value in extra-abdominal tumours, leukaemia or lymphoma of adult patients. This can be expected, since these markers cannot be histochemically located in the corresponding normal tissues.
Pregnancy-specific beta-l-glycoprotein (SPI) was originally isolated from human placenta (Bohn, 1971) , but closely related antigens have subsequently been found in various human cell lines (Rosen et al., 1979) . SPI is also shown to be a differentiation marker of the human myelomonocytic lineage (Heikinheimo et al., 1987) . These cells are capable of synthesising SP1. Serum concentration of SP1 has not been studied in disorders of the human haematopoietic system. SPI is structurally homologous with carcinoembryonic antigen (Rooney et al., 1988) , another oncofetal antigen present in serum samples from cancer patients. Thus far, the clinical usefulness of SPI has been associated with patients with trophoblast tumours (Rutanen et al., 1980) . This study was undertaken to evaluate the role of serum concentrations of the two monoclonal tumour markers CA 125, and CA 19-9, and the oncoplacental protein SPI in children with leukaemia and other malignancies.
Our study group consisted of 127 children with leukaemias or solid tumours, 51 girls and 76 boys, aged 0.2-16 years. Of the patients, 37 had acute lymphoblastic leukaemia, five had acute myeloid leukaemia, one had chronic myeloid leukaemia, 16 had lymphoma, ten had Wilm's tumour, 20 had neuroblastoma, 16 had brain tumour, nine had bone tumour and 13 had soft tissue sarcoma.
A serum sample was available from each patient at the time of diagnosis and from 63 patients at 1 to 8 weeks following diagnosis. In addition, serum samples from 52 healthy children, aged 1-17 years, collected for a nutritional study (Kallio et al., 1989) , were studied. Samples from 45 patients with acute infection without malignancy, and 12 children with active coeliac disease were available. The latter two groups were included since infections and various benign and malignant gastrointestinal diseases have been associated with elevated serum concentrations of the tumour markers .
Serum concentrations of CA 125, CA 19-9, SPI and AFP were measured using radioimmunoassays (Halila et al., 1986; Haglund et al., 1986a; Rutanen et al., 1980; Ruoslahti & Seppiila, 1971) . Statistical methods used were simple regression and correlation analyses and Student's t test.
The serum concentrations of CA 125, CA 19-9 and SPI were similar in healthy individuals and in patients with acute infection or coeliac disease (Table I ). The range of serum CA 19-9 levels in controls were clearly wider than in adults, and the values in some healthy individuals were more than 100 U 1'. The analysis of the data showed that the age of individuals did not have any influence on the concentrations of the three markers. Further, the concentrations were also mostly within the range of the reference group in patients with leukaemia or solid tumours at diagnosis (Figure 1) AFP levels were within the reference range in all 105 subjects studied. This is the first detailed study of the serum levels of tumour markers CA 19-9, CA 125 and SPI in healthy children and children with malignancies. The reference values for the paediatric age group were established.
Serum CA 19-9, CA 125 and SPI concentrations are used in the detection of germ cell tumours in children and in the follow-up of these children (Heikinheimo et al., 1986 ), but they are usually within normal limits in children with other malignancies. In some cases, however, the levels of CA 125 and SPI are slightly elevated at diagnosis but normalise soon after the induction of therapy. Although SPI has been shown to be a marker for the human myelocyte-monocyte lineage, children with acute myeloid leukaemia did not show elevated serum levels of SPI. The number of these patients was, however, low and further studies are needed to find out whether SPI is released to the serum during the induction phase of the treatment in these patients.
In this study, the highest CA 125 values were noted in three patients with abdominal Burkitt's lymphoma. Unfortunately follow-up samples were not available from these patients. Our fourth patient with Burkitt's lymphoma, localised to the tonsils, had a normal serum CA 125, and elevation of this marker in three other patients may reflect the gastrointestinal involvement of the disease, and be unrelated to the type of the tumour. On the other hand, markedly elevated CA 125 levels were occasionally seen in other tumours, in which an abdominal involvement could not always be demonstrated. More patients with Burkitt's lymphoma should, however, be studied and followed up, to see if this tumour marker associates with tumour load and might thus have clinical importance.
